BioTel Research is an industry leader in clinical trials testing services, monitoring, data and scientific consulting
BioTel Research provides expert imaging and cardiac core lab solutions for the advancement of biopharmaceutical development worldwide. Our organization monitors hundreds of thousands of patients and study subjects each year, supporting approximately 20,000 sites and supplying 30,000 devices monthly.
Each day, BioTel Research’s global clinical trials services team meets the demands of Phase I–IV studies for the world’s largest pharmaceutical organizations, specialty pharmaceutical firms, emerging biotechnology companies, contract research organizations (CRO’s) and medical device manufacturers.
We offer global operational support for cardiovascular monitoring in all therapeutic areas and advanced imaging analyses in oncology, cardiology, neurology and metabolic, musculoskeletal and medical device studies. Our research team comprises key opinion leaders, board-certified radiologists and cardiologists, sub-specialty scientists and skilled technicians. These experts aggregate, evaluate and share high-quality data through a state-of-the-art global infrastructure.
While our teams and infrastructure support studies in every corner of the world, we remain steadfast to our core promise of accessibility, reliability, and expertise in clinical trials.
Our industry-leading scientific and operational experts are carefully selected to complement and enhance your team.
We help you solve problems and create solutions. No matter where in the world. No matter what phase of study.
Join our VP, Musculoskeletal & Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, as they present alternative, noninvasive imaging methods to determine body composition at 10:00am on February 26th.
Stop by booth #41 to discover how BioTelemetry Research can optimize your upcoming global cardiac safety and advanced imaging clinical trial.
Join our Vice President of Musculoskeletal and Metabolic Imaging, Jonathan Riek, PhD, and AMRA’s Chief Scientific Officer & Co-Founder, Olof Dahlqvist Leinhard, PhD, as they present alternative, noninvasive imaging methods to determine body composition.
Feb 13, 2018 | 11:00 AM
Toll Free: 1.877.267.3324
Toll Free: 1.877.324.8326
Connect with us on LinkedIn for the latest thought leadership on remote clinical research.